Person who experienced the adverse event (patient)
Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6661217 | 7339072 | I | 6661217-9 | 20090730 | 20100323 | 20100331 | EXP | JP-ROCHE-694025 | ROCHE | 83 | M | Y | 50 | KG | 20100331 | MD | JAPAN |
Drug(s) used by person
Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
---|---|---|---|---|---|---|---|---|---|---|---|
6661217 | 1013420005 | PS | TOCILIZUMAB | 2 | INTRAVENOUS DRIP | ||||||
6661217 | 1013420006 | SS | REMICADE | 1 | ORAL | DOSE FORM: PERORAL AGENT | |||||
6661217 | 1013420007 | C | METHOTREXATE | 1 | ORAL | DOSE FORM: PERORAL AGENT | |||||
6661217 | 1013420008 | C | PREDNISOLONE | 1 | ORAL | DOSE FORM: PERORAL AGENT | |||||
6661217 | 1013420009 | C | LANSOPRAZOLE | 1 | ORAL | ||||||
6661217 | 1013420010 | C | LIPITOR | 1 | ORAL | ||||||
6661217 | 1013420011 | C | EUGLUCON | 2 | ORAL | ||||||
6661217 | 1013420012 | C | FOLIC ACID | 1 | ORAL | ||||||
6661217 | 1013420013 | C | MAGMITT | 2 | ORAL | ||||||
6661217 | 1013420014 | C | PRORENAL | 2 | ORAL | ||||||
6661217 | 1013420015 | C | FLIVAS | 2 | ORAL |
Indications of drugs used
Event ID | DRUG SEQ | INDI PT |
---|---|---|
6661217 | 1013420005 | RHEUMATOID ARTHRITIS |
6661217 | 1013420006 | RHEUMATOID ARTHRITIS |
Outcome of event
Event ID | OUTC COD |
---|---|
6661217 | HO |
Reactions reported
Event ID | PT |
---|---|
6661217 | BLADDER CANCER |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|
6661217 | 1013420005 | 20090723 | 20090723 | ||
6661217 | 1013420006 | 20080709 | 20090528 |